[PHARMA] QoQ Quarter Result on 30-Sep-2011 [#3]

Announcement Date
01-Nov-2011
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2011
Quarter
30-Sep-2011 [#3]
Profit Trend
QoQ- -22.33%
YoY- 25.91%
View:
Show?
Quarter Result
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
Revenue 456,737 446,745 367,786 371,432 396,435 385,328 376,116 13.83%
PBT 27,618 42,955 16,368 15,646 19,380 21,792 -2,701 -
Tax -11,541 -13,894 -4,186 -4,687 -5,335 -6,193 749 -
NP 16,077 29,061 12,182 10,959 14,045 15,599 -1,952 -
-
NP to SH 15,713 28,685 11,942 10,811 13,920 15,484 -2,256 -
-
Tax Rate 41.79% 32.35% 25.57% 29.96% 27.53% 28.42% - -
Total Cost 440,660 417,684 355,604 360,473 382,390 369,729 378,068 10.76%
-
Net Worth 481,394 474,161 514,153 464,092 451,517 437,661 421,262 9.31%
Dividend
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
Div 8,827 8,824 35,296 - - - - -
Div Payout % 56.18% 30.76% 295.57% - - - - -
Equity
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
Net Worth 481,394 474,161 514,153 464,092 451,517 437,661 421,262 9.31%
NOSH 117,700 117,657 117,655 106,933 106,994 107,007 106,919 6.62%
Ratio Analysis
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
NP Margin 3.52% 6.51% 3.31% 2.95% 3.54% 4.05% -0.52% -
ROE 3.26% 6.05% 2.32% 2.33% 3.08% 3.54% -0.54% -
Per Share
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
RPS 388.05 379.70 312.60 347.35 370.52 360.09 351.78 6.76%
EPS 13.35 24.38 10.15 10.11 13.01 14.47 -2.11 -
DPS 7.50 7.50 30.00 0.00 0.00 0.00 0.00 -
NAPS 4.09 4.03 4.37 4.34 4.22 4.09 3.94 2.52%
Adjusted Per Share Value based on latest NOSH - 106,933
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
RPS 31.69 31.00 25.52 25.77 27.51 26.74 26.10 13.82%
EPS 1.09 1.99 0.83 0.75 0.97 1.07 -0.16 -
DPS 0.61 0.61 2.45 0.00 0.00 0.00 0.00 -
NAPS 0.334 0.329 0.3567 0.322 0.3133 0.3037 0.2923 9.30%
Price Multiplier on Financial Quarter End Date
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
Date 29/06/12 30/03/12 30/12/11 30/09/11 30/06/11 31/03/11 30/12/10 -
Price 10.18 5.90 5.36 5.90 5.90 5.73 5.31 -
P/RPS 2.62 1.55 1.71 1.70 1.59 1.59 1.51 44.44%
P/EPS 76.25 24.20 52.81 58.36 45.35 39.60 -251.66 -
EY 1.31 4.13 1.89 1.71 2.21 2.53 -0.40 -
DY 0.74 1.27 5.60 0.00 0.00 0.00 0.00 -
P/NAPS 2.49 1.46 1.23 1.36 1.40 1.40 1.35 50.45%
Price Multiplier on Announcement Date
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
Date 08/08/12 03/05/12 22/02/12 01/11/11 10/08/11 13/05/11 25/02/11 -
Price 8.83 5.90 5.90 5.90 5.90 5.05 5.35 -
P/RPS 2.28 1.55 1.89 1.70 1.59 1.40 1.52 31.06%
P/EPS 66.14 24.20 58.13 58.36 45.35 34.90 -253.55 -
EY 1.51 4.13 1.72 1.71 2.21 2.87 -0.39 -
DY 0.85 1.27 5.08 0.00 0.00 0.00 0.00 -
P/NAPS 2.16 1.46 1.35 1.36 1.40 1.23 1.36 36.16%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment